


NanoDx Revenue
Medical Equipment Manufacturing • Southborough, Massachusetts, United States • 21-50 Employees
NanoDx revenue & valuation
| Annual revenue | $3,165,535 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Medical Equipment Manufacturing industry and current estimated revenues | $10,200,000 |
| Total funding | No funding |
Key Contacts at NanoDx
Lisa Clarizia
Director Of Assay Development
Fabian Reza
Associate Director, Engineering And Operations
Jennifer Newman
Director Of Human Resources
Mike Gibney
Director, Clinical And Market Development
Company overview
| Headquarters | 144 Turnpike Rd., Suite 110, Southborough, MA 01772, US |
| Phone number | +15085992400 |
| Websites | |
| SIC | 384 |
| Keywords | Nanotechnology, Biomarkers, Neuroscience, Diagnostics, Medical Device, Mental Health, Traumatic Brain Injury, Precision Medicine, Concussion, TBI, Concussion Awareness, Brain Injury Awareness, Poc Diagnostics, Braininjury |
| Founded | 2010 |
| Employees | 21-50 |
| Socials |
NanoDx Email Formats
NanoDx uses 3 email formats. The most common is {first initial}{last name} (e.g., jdoe@nanodiagnostics.com), used 58.6% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@nanodiagnostics.com | 58.6% |
{first name}{last name} | johndoe@nanodiagnostics.com | 37.9% |
{last name}{last name} | doedoe@nanodiagnostics.com | 3.4% |
About NanoDx
NanoDx, Inc. is a privately-held, U.S. based, medical device company developing rapid point-of-care and in-vitro diagnostic products on its proprietary nanowire biosensor platform. The NanoDx™ System provides for direct measurement of blood and saliva analytes normally in less than 2 minutes from either a drop of whole blood or a small sample of saliva. In partnership with IBM and SkyWater Technologies, a low-cost, high-volume, licensed CMOS process has been integrated into NanoDx’s highly-advanced proprietary platform. The System consists of a single-use, disposable test cartridge and an analyzer. The company is focused on two near-term indications: traumatic brain injury (TBI) and Covid-19. The NanoDx™ System offers compelling competitive advantages based on its ultra-sensitivity and accuracy, speed, value, and ease-of-use. Additional potential diseases and conditions include stroke, sepsis, influenza and inflammatory diseases. FDA has not yet reviewed this product and it has not been cleared. Currently for research use only.
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
NanoDx has 19 employees across 8 departments.
Departments
Number of employees
Funding Data
NanoDx has never raised funding before.
NanoDx Tech Stack
Discover the technologies and tools that power NanoDx's digital infrastructure, from frameworks to analytics platforms.
Video players
Form builders
JavaScript libraries
Font scripts
JavaScript libraries
Programming languages
WordPress plugins
Blogs
Analytics
SEO
Tag managers
Frequently asked questions
4.8
40,000 users



